The Sialorrhea market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2017 to 2030. It evaluates the current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Sialorrhea: An Overview
Sialorrhea, also known as Ptyalis, is the condition of excessive drooling in children with cerebral palsy and adults who suffers from neurodegenerative disorders. Drooling is of two types, anterior and posterior drooling. Anterior drooling is defined as saliva spilled from the mouth that is clearly visible. When saliva spills through the oropharynx and into the hypopharynx it is known as posterior drooling.
Sialorrhea Market Key Facts
In 2017, there were 2,484,780 cases of Sialorrhea in 7MM, amongst which the United States accounted for the most prevalent cases, with 1,132,426 cases in 2017.
Among the five major European Markets (EU5), the total number of prevalent cases of Sialorrhea was found to be 999,549 in 2017, with the highest prevalent cases were observed in Germany. Spain accounted for the least prevalent population of Sialorrhea with 180,184 cases in 2017.
In Japan, the cases of PD-induced Sialorrhea were observed to be highest, however, multiple sclerosis induced Sialorrhea accounted for the least number of cases in Japan.
According to DelveInsight, the therapeutic market of Sialorrhea in seven major markets was USD 1073.62 Million in 2017 and is expected to increase during the forecast period. Among the 7MM, the United States accounts for the largest market size of Sialorrhea, in comparison to EU5 (the United Kingdom, Germany, Italy, France, and Spain) and Japan.
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Sialorrhea market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.
The report gives a thorough detail of the Sialorrhea market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Get the sample copy at Sialorrhea Therapeutics Market
The epidemiology section covers insights about the historical and current Sialorrhea patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Sialorrhea Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Sialorrhea market or expected to get launched in the market during the study period. The analysis covers the Sialorrhea market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Sialorrhea Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.
Currently, the treatment market for Sialorrhea comprises both prescribed and off-label medication. But, due to the expected launch of drugs in the later stage of development, the treatment market is anticipated to shift towards the approved medication.
Key Companies in the Sialorrhea Market includes:
Proveca Pharma Ltd
And many others.
Sialorrhea Therapies covered in the report include:
Sialanar (glycopyrronium bromide)
And many more.
Request for Sample @ Sialorrhea Emerging Therapies and Key Companies
Table of Content
1. Key Insights
2. Executive Summary
3. Sialorrhea Competitive Intelligence Analysis
4. Sialorrhea Market Overview at a Glance
5. Sialorrhea Disease Background and Overview
6. Sialorrhea Patient Journey
7. Sialorrhea Epidemiology and Patient Population
8. Sialorrhea Treatment Algorithm, Current Treatment, and Medical Practices
9. Sialorrhea Unmet Needs
10. Key Endpoints of Sialorrhea Treatment
11. Sialorrhea Marketed Products
12. Sialorrhea Emerging Therapies
13. Sialorrhea Seven Major Market Analysis
14. Attribute Analysis
15. Sialorrhea Market Outlook (7 major markets)
16. Sialorrhea Access and Reimbursement Overview
17. KOL Views on the Sialorrhea Market.
18. Sialorrhea Market Drivers
19. Sialorrhea Market Barriers
21. DelveInsight Capabilities
*The table of contents is not exhaustive; the final content may vary.
Get FREE sample copy at: https://www.delveinsight.com/sample-request/sialorrhea-market
Latest Report by DelveInsight
DelveInsight’s “Nicotine Addiction Market Insights, Epidemiology and Market Forecast 2030” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Nicotine Addiction market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States